We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Roche has teamed up with Eli Lilly to develop Roche’s Elecsys Amyloid Plasma Panel (EAPP), an investigational blood-based biomarker test designed to give patients an earlier Alzheimer’s disease diagnosis. Read More
Theravance Biopharma and Viatris have alleged that multiple competitors infringed on patent protections for Yupelri (revefenacin) — a combination drug-device product used to treat chronic obstructive pulmonary disease (COPD) — by developing generic versions.
New York, N.Y.-based cardiac artificial intelligence (AI) company Cleerly has partnered with ClearDATA, a data security company headquartered in Austin, Texas, to protect health data collected as part of Cleerly’s coronary analysis studies.
Insulet has completed two asset purchases that should about double the Massachusetts-based company’s portfolio of pump and automated insulin delivery (AID) technologies.
GE Healthcare is acquiring Caption Health, a California-based company that uses artificial intelligence (AI) solutions for early detection of heart disease in ultrasound scans.
Abbott is expanding its portfolio of cardiovascular devices through an $890 million purchase of St. Paul, Minn.-based Cardiovascular Systems (CSI) and its orbital atherectomy system.